IL0011595993 - Common Stock
INMODE LTD
NASDAQ:INMD (5/3/2024, 1:22:39 PM)
17.55
+0.19 (+1.09%)
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
INMODE LTD
Tavor Building, Sha'ar Yokneam, Pob 533
Yokneam 2069200
P: 97249097470
CEO: Moshe Mizrahy
Employees: 480
Website: https://inmodemd.com/
INMD earnings call for the period ending March 31, 2024.
INMD stock results show that InMode missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial...
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021...
WHY: NEW YORK, NY - (NewMediaWire) - April 15, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021 and October 12, 2023, both dates inclusive (the “Class Period”), of the important April 15, 2024 lead plaintiff deadline.
Here you can normally see the latest stock twits on INMD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: